- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 19 results
Article · Source: Washington Legal Foundation
June 24, 2022
Georgia Supreme Court Declines to Adopt Apex Doctrine but Offers Some Protection to High-Ranking Executives
Client Alert
May 25, 2022
Morgan v. Sundance: Prejudice Not Required To Waive Arbitration Rights
Newsletter
April 11, 2022
Health Headlines – April 11, 2022
Client Alert
March 22, 2022
Morgan v. Sundance argument: Is an arbitration clause “use it or lose it”?
Client Alert
January 19, 2022
Cassirer Argument: Ownership of Nazi-looted art to be determined by choice-of-law
Article · Source: Chamber Litigation Blog
May 25, 2021
Stats Without Facts: Another Court Rejects Data Mining Qui Tam Strategy
Client Alert
May 5, 2021
Genus Medical Technologies LLC v. FDA: D.C. Circuit Holds FDA Cannot Regulate Devices as Drugs
Article · Source: Offshore Magazine
February 3, 2021
Legal commentary: Federal statute will underpin challenges to Biden’s executive orders
Article · Source: Offshore Magazine
February 3, 2021
Legal commentary: Federal statute will underpin challenges to Biden’s executive orders
Article · Source: Texas Lawyer
January 19, 2021
Executive Action Aimed at Fossil Fuels
Client Alert
December 31, 2020
Final Rule on VBP, Patient Assistance and Line Extensions Presents Opportunity and Risk for Drug Manufacturers
Client Alert
December 14, 2020
HHS Finalizes 340B Administrative Dispute Resolution Process